Dr. Daniel A Monti, MD, MBA
Claim this profileStudies Multiple Sclerosis
Studies Systemic Sclerosis
1 reported clinical trial
1 drug studied
More about Daniel A Monti, MD, MBA
Clinical Trial Related8 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Daniel A Monti, MD, MBA has experience with
- N-acetyl Cysteine
Breakdown of trials Daniel A Monti, MD, MBA has run
Multiple Sclerosis
Systemic Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel A Monti, MD, MBA specialize in?
Daniel A Monti, MD, MBA focuses on Multiple Sclerosis and Systemic Sclerosis. In particular, much of their work with Multiple Sclerosis has involved treating patients, or patients who are undergoing treatment.
Is Daniel A Monti, MD, MBA currently recruiting for clinical trials?
No, Daniel A Monti, MD, MBA is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Daniel A Monti, MD, MBA has studied deeply?
Yes, Daniel A Monti, MD, MBA has studied treatments such as N-acetyl Cysteine.
What is the best way to schedule an appointment with Daniel A Monti, MD, MBA?
Apply for one of the trials that Daniel A Monti, MD, MBA is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.